EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The effect of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial

Jyrki K Virtanen, Sari Hantunen, Niko Kallio, Christel Lamberg-Allardt, JoAnn E Manson, Tarja Nurmi, Jussi Pihlajamäki, Matti Uusitupa, Ari Voutilainen, Tomi-Pekka Tuomainen

Diabetologia · 2025

DOI: 10.1007/s00125-024-06336-9 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetologia, 2025. Verfasst von Jyrki K Virtanen und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Eastern Finland, Institute of Public Health and Clinical Nutrition, Kuopio, Finland. jyrki.virtanen@uef.fi. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cholecalciferol. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Diabetestutkimussäätiö, Medicinska Understödsföreningen Liv och Hälsa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Vitamin D insufficiency is associated with an elevated risk of type 2 diabetes, but evidence from randomised trials on the benefits of vitamin D supplementation is limited, especially for average-risk populations. The Finnish Vitamin D Trial (FIND) investigated the effects of vitamin D 3 supplementation at two different doses on the incidence of type 2 diabetes in a generally healthy older adult population.

Methods

FIND was a 5 year randomised placebo-controlled, parallel-arm trial among 2271 male and female participants aged ≥60 years and ≥65 years, respectively, from a general Finnish population who were free of CVD or cancer and did not use diabetes medications. The study had three arms: placebo, 1600 IU/day of vitamin D 3 or 3200 IU/day of vitamin D 3 . A non-study group statistician carried out sex-stratified simple randomisation in a 1:1:1 ratio, based on computerised random number generation. The participants, investigators and study staff were masked to group assignment. National health registries were used to collect event data. A representative subcohort of 505 participants had more detailed in-person investigations at months 0, 6, 12 and 24.

Results

During the mean follow-up of 4.2 years, there were 38 (5.0%), 31 (4.2%) and 36 (4.7%) type 2 diabetes events in the placebo ( n =760), 1600 IU/day vitamin D 3 ( n =744; vs placebo: HR 0.81; 95% CI 0.50, 1.30) and 3200 IU/day vitamin D 3 ( n =767; vs placebo: HR 0.92, 95% CI 0.58, 1.45) arms, respectively ( p -trend=0.73). When the two vitamin D 3 arms were combined and compared with the placebo arm, the HR was 0.86 (95% CI 0.58, 1.29). In the analyses stratified by BMI (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2CholecalciferolHumansMaleFemaleAgedMiddle AgedDietary SupplementsIncidenceFinlandVitamin D DeficiencyRisk Factors

Stichwörter der Autor:innen

BMIExperimental studyOlder adultsType 2 diabetesVitamin D3

Substanzen

Cholecalciferol

Autor:innen und Institutionen

  • University of Eastern Finland, Institute of Public Health and Clinical Nutrition, Kuopio, Finland. jyrki.virtanen@uef.fi.
  • University of Eastern Finland, Institute of Public Health and Clinical Nutrition, Kuopio, Finland.
  • University of Eastern Finland, School of Pharmacy, Kuopio, Finland.
  • University of Helsinki, Department of Food and Nutrition, Helsinki, Finland.
  • Department of Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, MA, USA.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Förderung

  • Research Council of Finland
  • Diabetestutkimussäätiö
  • Medicinska Understödsföreningen Liv och Hälsa
  • Juho Vainion Säätiö
  • Itä-Suomen Yliopisto
  • Suomen Kulttuurirahasto
  • Sydäntutkimussäätiö
  • University of Eastern Finland

Zitieren

APA

Virtanen, J. K., Hantunen, S., Kallio, N., Lamberg-Allardt, C., Manson, J. E., Nurmi, T., Pihlajamäki, J., Uusitupa, M., Voutilainen, A., & Tuomainen, T. P. (2025). The effect of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial. Diabetologia. https://doi.org/10.1007/s00125-024-06336-9

Vancouver

Virtanen JK, Hantunen S, Kallio N, Lamberg-Allardt C, Manson JE, Nurmi T, et al. The effect of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial. Diabetologia. 2025. doi:10.1007/s00125-024-06336-9

BibTeX
@article{Virtanen2025,
  author = {Virtanen, Jyrki K and Hantunen, Sari and Kallio, Niko and Lamberg-Allardt, Christel and Manson, JoAnn E and Nurmi, Tarja and Pihlajamäki, Jussi and Uusitupa, Matti and Voutilainen, Ari and Tuomainen, Tomi-Pekka},
  title = {The effect of vitamin D3 supplementation on the incidence of type 2 diabetes in healthy older adults not at high risk for diabetes (FIND): a randomised controlled trial},
  journal = {Diabetologia},
  year = {2025},
  doi = {10.1007/s00125-024-06336-9}
}
Kostenlos starten →